Guofang Bi
Guangdong Pharmaceutical University(CN)National Medical Products Administration(CN)Southern Medical University(CN)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Hippo pathway signaling and YAP/TAZ, Gut microbiota and health, Liver physiology and pathology, Ubiquitin and proteasome pathways
Most-Cited Works
- → PXR triggers YAP-TEAD binding and Sirt2-driven YAP deacetylation and polyubiquitination to promote liver enlargement and regeneration in mice(2023)29 cited
- → Schisandrol B alleviates depression-like behavior in mice by regulating bile acid homeostasis in the brain-liver-gut axis via the pregnane X receptor(2024)13 cited
- → Parabacteroides distasonis promotes liver regeneration by increasing β-hydroxybutyric acid (BHB) production and BHB-driven STAT3 signals(2025)12 cited
- → Time-Dependent Distribution of Hydroxychloroquine in Cynomolgus Macaques Using Population Pharmacokinetic Modeling Method(2021)11 cited
- → Association analysis of SNPs present in plasma with adverse events and population pharmacokinetics in Chinese sunitinib treated patients with renal cell carcinoma(2018)8 cited
- → The Skin-Brain Axis in Psoriasis and Depression: Roles of Inflammation, Hormones, Neuroendocrine Pathways, Neuropeptides, and the Microbiome(2025)5 cited